Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
02/22/17 • 21 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/industry-focus-133361/healthcare-carl-icahn-takes-aim-at-bristol-myers-squibb-6557692"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to healthcare: carl icahn takes aim at bristol-myers squibb on goodpods" style="width: 225px" /> </a>
Copy